¼ºñ½º »óǰ
¸®¼Ä¡ Á¤º¸
°í°´¼¾ÅÍ
°øÁö»çÇ×
´Ù¿î·Îµå
Financial
Information
e-Bond
Revolution
Market
Transparency
BONDWEB ½Ã½ºÅÛÀº ²÷ÀÓ¾ø´Â Á¤º¸Çõ½ÅÀ» ÅëÇØ ±ÝÀ¶ ¼±ÁøÈ¿¡ ±â¿©ÇÕ´Ï´Ù.
BONDWEB
º»µåÀ¥Plus
ÃֱٰԽù°
°æÁ¦Á¾ÇÕ´º½º
º¸µµÀÚ·á
½Ã°¡Æò°¡Ç¥
ÁÖ¿ä±Ý¸®
IRS/CRS
½ºÅ©·¦
ÇïÇÁµ¥½ºÅ©
´Ù¿î·Îµå¼¾ÅÍ
°øÁö»çÇ× & ´º½º
ÀÎÀçã±â
ENG
ÀÏÀÚ
ÆÄÀÏ
Á¦¸ñ
±â°ü¸í
04-28
[Albemarle Corporation(ALB-US)] Á¡Â÷ °³¼±µÇ¾î°¡´Â ¸®Æ¬ ¼ö±Þ
ÇÏÀÌÅõÀÚÁõ±Ç
04-28
[LSÁõ±Ç Ȳ»êÇØ] ¸®½ºÅ©¿Í ÀÌÀÍ »çÀÌ ±â¼úÁÖ Â÷º°È ·¤¸® Áö¼Ó
LSÁõ±Ç
04-28
[¸Þ¸®Ã÷Áõ±Ç/Ȳ¼ö¿í] Meritz Strategy Daily :[Àü·«°ø°¨ 2.0] ±¸..
¸Þ¸®Ã÷Áõ±Ç
04-28
[À¯Áø/ÀÌÀçÀÏ]ÄÉÀÌÄ« - 1Q26 Preview: ´ëÁÖÁÖ º¯°æ ÀÌÈİ¡ °ü°Ç
À¯ÁøÅõÀÚÁõ±Ç
04-28
[¸Þ¸®Ã÷Áõ±Ç/¾ç½Â¼ö] LGÀ̳ëÅØ(011070):°ÈµÇ´Â ±àÁ¤Àû ½Ã±×³Î
¸Þ¸®Ã÷Áõ±Ç
04-28
[Ű¿ò ETF ±èÁø¿µ] ´º ETF ¶óÀÎ ¾÷ : KQ150+ä±Ç, Ú¸ AI+±¹Ã¤, Ú¸..
Ű¿òÁõ±Ç
04-28
[´Ù¿ÃÅõÀÚÁõ±Ç ÃÖ±¤½Ä] HD°Ç¼³±â°è(267270) - 1Q26 Review: °¡ÀÌ..
´Ù¿ÃÅõÀÚÁõ±Ç
04-28
[IPARKÇö´ë»ê¾÷°³¹ß/Buy] 1Q26 Re: °í¹«ÀûÀÎ ÀÌÀÍ·ü, ¾Æ½¬¿î ¿ÜÇü..
ÇÏÀÌÅõÀÚÁõ±Ç
04-28
[Pharmaceuticals/Bio ÇÏÇö¼ö] µ¿¾Æ¿¡½ºÆ¼ : 1Q26Re: ºñ¿ë ÅëÁ¦·Î..
À¯¾ÈŸÁõ±Ç
04-28
[Ű¿ò Á¶¼±/±â°è/¹æ»ê/Ç×°ø¿ìÁÖ ÀÌÇѰá] HD°Ç¼³±â°è (267270): °Ç..
Ű¿òÁõ±Ç
04-28
[LGÀ̳ëÅØ/Buy] ÆÐŰÁö¼Ö·ç¼ÇÀÌ ½Ã°¡ÃѾ×ÀÇ Àý¹Ý ÀÌ»óÀ» ¼³¸í
ÇÏÀÌÅõÀÚÁõ±Ç
04-28
[¼ºÁ¾È À¯Æ¿¸®Æ¼] À¯Æ¿¸®Æ¼ Weekly ÁÖ¿ä ÁöÇ¥ ¾÷µ¥ÀÌÆ®
LSÁõ±Ç
04-28
[À¯Áø/½º¸ôĸ/¹ÚÁ¾¼±]¾¾¿¥Æ¼¿¢½º(388210,KQ) - ¼ºÀ强, ¼öÀͼº ¸ð..
À¯ÁøÅõÀÚÁõ±Ç
04-28
[Pharmaceuticals/Bio ÇÏÇö¼ö] ¿¡½ºÆ¼ÆÊ : 1Q26Re: ¾ÈÁ¤ÀûÀÎ ¼öÁÖ..
À¯¾ÈŸÁõ±Ç
04-28
[ÇÑÈÅõÀÚÁõ±Ç ¹è¼ºÁ¶][Á¶¼±] ÇÑÈ¿À¼Ç[042660/Buy] [1Q26 Revie..
ÇÑÈÅõÀÚÁõ±Ç
Àüü : 476
óÀ½
ÀÌÀü
[6]
[7]
[8]
[9]
[10]
´ÙÀ½
³¡À¸·Î
Ȩ > ¸®¼Ä¡Á¤º¸ >
ÃֱٰԽù°